These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35766901)

  • 1. Human Immortalized Cell-Based Blood-Brain Barrier Spheroid Models Offer an Evaluation Tool for the Brain Penetration Properties of Macromolecules.
    Kitamura K; Okamoto A; Morio H; Isogai R; Ito R; Yamaura Y; Izumi S; Komori T; Ito S; Ohtsuki S; Akita H; Furihata T
    Mol Pharm; 2022 Aug; 19(8):2754-2764. PubMed ID: 35766901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines.
    Kitamura K; Umehara K; Ito R; Yamaura Y; Komori T; Morio H; Akita H; Furihata T
    Biol Pharm Bull; 2021 Jul; 44(7):984-991. PubMed ID: 33896887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized Preclinical
    Morrison JI; Petrovic A; Metzendorf NG; Rofo F; Yilmaz CU; Stenler S; Laudon H; Hultqvist G
    Mol Pharm; 2023 Mar; 20(3):1564-1576. PubMed ID: 36808999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
    Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
    Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
    Clark AJ; Davis ME
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a Human Conditionally Immortalized Cell-based Multicellular Spheroidal Blood-Brain Barrier Model for Permeability Evaluation of Macromolecules.
    Isogai R; Morio H; Okamoto A; Kitamura K; Furihata T
    Bio Protoc; 2022 Aug; 12(15):e4465. PubMed ID: 36082368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human.
    Zhang W; Liu QY; Haqqani AS; Leclerc S; Liu Z; Fauteux F; Baumann E; Delaney CE; Ly D; Star AT; Brunette E; Sodja C; Hewitt M; Sandhu JK; Stanimirovic DB
    Fluids Barriers CNS; 2020 Jul; 17(1):47. PubMed ID: 32698806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
    Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
    Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional validation of the simplified in vitro 3D Co-culture based BBB model.
    Kim W; Kim J; Lee SY; Kim HM; Jung H; Joo KM; Nam DH
    Biochem Biophys Res Commun; 2022 Oct; 625():128-133. PubMed ID: 35961136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
    Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
    MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
    Choi ES; Shusta EV
    Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse embryonic stem cell-derived blood-brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis.
    Jezierski A; Huang J; Haqqani AS; Haukenfrers J; Liu Z; Baumann E; Sodja C; Charlebois C; Delaney CE; Star AT; Liu Q; Stanimirovic DB
    Fluids Barriers CNS; 2023 May; 20(1):36. PubMed ID: 37237379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies.
    Stanimirovic D; Kemmerich K; Haqqani AS; Farrington GK
    Adv Pharmacol; 2014; 71():301-35. PubMed ID: 25307221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
    Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
    Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
    Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
    J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
    Stanimirovic DB; Sandhu JK; Costain WJ
    BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
    Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
    Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological blood-brain transport is impaired with age by a shift in transcytosis.
    Yang AC; Stevens MY; Chen MB; Lee DP; Stähli D; Gate D; Contrepois K; Chen W; Iram T; Zhang L; Vest RT; Chaney A; Lehallier B; Olsson N; du Bois H; Hsieh R; Cropper HC; Berdnik D; Li L; Wang EY; Traber GM; Bertozzi CR; Luo J; Snyder MP; Elias JE; Quake SR; James ML; Wyss-Coray T
    Nature; 2020 Jul; 583(7816):425-430. PubMed ID: 32612231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated transcytosis of macromolecules across the blood-brain barrier.
    Baghirov H
    Expert Opin Drug Deliv; 2023; 20(12):1699-1711. PubMed ID: 37658673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.